WassermanD,SanchezD,ScottK,McMichealA, 2007.Alopecia areata,Int J Dermatol 46 121 -31
Taisuke,YoshikiI, 2011.The role of cytokines and chemokines in the T-cell-mediated autoimmune process in alopecia areata,Exp Dermatol 11 787 -91
MessengerAG,BurnsT,BreathnachS,CoxN,GriffithsC,Wiley-Blackwell Publishing, 2010.Rook's textbook of dermatology, 31 -66
Galan-GutierrezM,Rodriguez-BujaldonA,Moreno-GimenezJC, 2009.Update on the treatment of alopecia areata,Adv Dermatol 100 266 -76
AlkhalifaA, 2011.Topical and intralesional therapies for alopecia areata,Dermatol Ther 24 355 -63
OtbergN., 2011.Systemic treatment for alopecia areata,Dermatol Ther 24 320 -5
ThomasEA,KadyanRS, 2008.Alopecia areata and autoimmunity: a clinical study,Indian J Dermatol 53 70 -4
Al-MultairiN,EldinON., 2011.Clinical profile and impact on quality of life: seven years experience with patients of alopecia,Indian J Dermatol Venerol Leprol 77 489 -93
KumaresanM., 2010.Intralesional steroids for alopecia areata,Inter J Tricholol 2 63 -5
KuldeepCM,SinghalH,KhareAK,MittalA,GuptaLK,GargA, 2011.Randomized comparison of topical betamethasone valearate foam, intralesional triamcinolone acetonide and tacrolimus ointment in management of localized alopecia areata,Inter J Trichol 3 20 -24
QiS,XuF,ShengY,YangQ, 2015.Assessing quality of life in alopecia areata patients in China,Psychol Health Med 20 97 -102
MasmoudiJ,SellamiR,OualiU,MnifL,FekiI,AmouriM, 2013.Quality of life in alopecia areata: a sample of Tunisian patients,Dermatol Res Pract 983804 -
PriceVH, 1991.Alopecia areata; clinical aspects,J Invest Dermatol 96 68S -
DrakeLA,CeilleyRI,CornelisionRL,DobesWL,DornerW,GoltzRW, 1992.Guidelines of care for alopecia areata,J Am Acad Dermatol 26 247 -50
AlkhalifahA,AlsantaliA,WangE,McElweeKJ,ShapiroJ, 2010.,Alopecia areata update: Part II. Treatment. J Am Acad Dermatol 62 191 -202
HordinskyM,DonatiA, 2014.Alopecia areata: an evidence-based treatment update,Am J Clin Dermatol 15 231 -46
MancusoG,BalducciA,CasadioC,FarinaP,StaffaM,ValentiL, 2003.Efficacy of betamethasone valearate foam formulation in comparison with betamethasone dipropionate lotion in treatment of mild to moderate alopecia areata: multicentric, prospective, randomized, controlled, investigator -blinded trial,Int J Dermatol 42 572 -5
TostiA,IorizzoM,BottaGL,MilaniM. Efficacy, 2006.and safety of a new clobetasol propionate 0.05% foam in alopecia areata: A randomized double blind placebo controlled trial,J Euro Acad Dermatol Venereol 20 1243 -7
2006.Prescriber update,Topical steroids and skin damage. WHO Drug Inf Bull 20 1 -
PorterD,BurtonJL, 1971.Comparison of intralesional triamcinolone hexacetonide and triamcinolone acetonide in alopecia areata,Br J Dermatol 85 272 -3